Neuronetics, Inc. (STIM) shareholders
Close on Nov 17, 2026Market cap $97.53MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Madryn Asset Management, LP Joint filing with Madryn Health Advisors Ii, LP (27.00%), Madryn Health Advisors Gp Ii, LLC (27.00%) and 1 more | 20,737,061 | 30.30% | 13D (active) amendment | Mar 2, 2026 |
| Chernett Jorey | 10,602,988 | 13.92% | 13D (active) amendment | Aug 14, 2026 |
| Parian Ultreia LP | 4,844,908 | 7.00% | 13G (passive) | Mar 17, 2026 |
| Point72 Capital Advisors, Inc. Joint filing with Point72 Asset Management, L.P. (5.00%), Steven A. Cohen (5.00%) | 3,822,124 | 5.00% | 13G (passive) | Aug 13, 2026 |
| Kent Lake Partners LP Joint filing with Kent Lake PR LLC (6.90%), Benjamin Natter (6.90%) | 2,077,848 | 6.90% | 13G (passive) | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of STIM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Madryn Asset Management, LP | 18,540,488 | 24.33% | $24.10M | +64,595 | 65.29% |
| UBS Group AG | 2,279,099 | 2.99% | $2.96M | −591,499 | 0.00% |
| Wexford Capital LP | 2,002,625 | 2.63% | $2.60M | +1,301,664 | 0.33% |
| FourWorld Capital Management LLC | 1,744,142 | 2.29% | $2.27M | +254,820 | 2.06% |
| Lane Generational LLC | 1,633,372 | 2.14% | $2.12M | −141,252 | 1.86% |
| Vanguard Capital Management LLC | 1,507,097 | 1.98% | $1.96M | −540,878 | 0.00% |
| Masters Capital Management LLC | 1,000,000 | 1.31% | $1.30M | – | 0.03% |
| AdvisorShares Investments LLC | 742,795 | 0.97% | $965.63K | +125,602 | 0.12% |
| Ikarian Capital, LLC | 701,182 | 0.92% | $911.54K | – | 0.10% |
| BlackRock, Inc. | 596,622 | 0.78% | $775.61K | −1,721,915 | 0.00% |
| HighTower Advisors, LLC | 563,741 | 0.74% | $732.86K | +1,371 | 0.00% |
| Marshall Wace, Llp | 485,692 | 0.64% | $631.40K | New | 0.00% |
| Geode Capital Management, LLC | 458,474 | 0.60% | $596.24K | −500,515 | 0.00% |
| Citadel Advisors LLC | 421,903 | 0.55% | $548.47K | +345,306 | 0.00% |
| Dauntless Investment Group, LLC | 369,187 | 0.48% | $479.94K | +99,979 | 0.38% |
| State Street Corp | 290,299 | 0.38% | $377.39K | −552,248 | 0.00% |
| Centiva Capital, LP | 285,913 | 0.38% | $371.69K | +116,594 | 0.00% |
| Vanguard Fiduciary Trust Co | 264,734 | 0.35% | $344.15K | +6,700 | 0.00% |
| Goldman Sachs Group Inc | 264,088 | 0.35% | $343.31K | +30,498 | 0.00% |
| JBF Capital, Inc. | 233,166 | 0.31% | $303.12K | – | 0.04% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 87 | 37M | 48.8% | 17 / 29 | 25 / 28 | 4M | 8M |
| Q1 2026 | 99 | 42M | 54.7% | 28 / 25 | 23 / 22 | 6M | 4M |
| Q4 2025 | 95 | 42M | 55.5% | 15 / 32 | 27 / 18 | 25M | 4M |
| Q3 2025 | 100 | 21M | 27.9% | 21 / 38 | 21 / 11 | 6M | 3M |
| Q2 2025 | 90 | 18M | 23.7% | 23 / 27 | 21 / 35 | 5M | 4M |
| Q1 2025 | 102 | 17M | 22.5% | 62 / 15 | 12 / 4 | 11M | 2M |
| Q4 2024 | 45 | 8M | 9.9% | 11 / 9 | 10 / 14 | 2M | 5M |
| Q3 2024 | 48 | 11M | 13.9% | 8 / 8 | 14 / 25 | 5M | 10M |
| Q2 2024 | 67 | 18M | 23.0% | 8 / 18 | 25 / 7 | 2M | 3M |
| Q1 2024 | 66 | 18M | 23.3% | 11 / 21 | 19 / 11 | 3M | 1M |
| Q4 2023 | 66 | 16M | 20.9% | 13 / 11 | 25 / 3 | 1M | 3M |
| Q3 2023 | 56 | 17M | 22.8% | 3 / 13 | 26 / 16 | 3M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
76 funds held STIM in Q1 2026, 70% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of STIM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,056,478 | 1.39% | $1.37M | 0.00% | Jun 30, 2026 |
| AdvisorShares Psychedelics ETF | 742,795 | 0.97% | $965.63K | 2.17% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 424,323 | 0.56% | $551.62K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 217,184 | 0.29% | $334.46K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 189,766 | 0.25% | $292.24K | 0.00% | May 31, 2026 |
| Ultra-Small Company Market Fund | 95,205 | 0.12% | $123.77K | 0.08% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 93,494 | 0.12% | $121.54K | 0.01% | Jun 30, 2026 |
| Goldman Sachs Absolute Return Tracker Fund | 87,050 | 0.11% | $113.17K | 0.00% | Jun 30, 2026 |
| 1290 VT GAMCO Small Company Value Portfolio | 75,000 | 0.10% | $97.50K | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 69,400 | 0.09% | $106.88K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 58,666 | 0.08% | $90.35K | 0.00% | May 31, 2026 |
| Invesco NASDAQ Future Gen 200 ETF | 57,343 | 0.08% | $88.31K | 0.47% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 45,586 | 0.06% | $70.20K | 0.00% | May 31, 2026 |
| AQR Small Cap Momentum Style Fund | 36,487 | 0.05% | $52.91K | 0.03% | Mar 31, 2026 |
| Vanguard Russell 2000 Growth Index Fund | 35,270 | 0.05% | $54.32K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Nir Naor | EVP, CFO & Treasurer | 500,000 | 0.66% | Jul 23, 2026 |
| Cory Anderson | EVP & Gen. Manager, Greenbrook | 55,003 | 0.07% | Jul 13, 2026 |
| Steven Pfanstiel | Former EVP, CFO and Treasurer | 836,643 | 1.10% | May 21, 2026 |
| Francis X. Brown Iii | Interim PAO | 19,968 | 0.03% | May 13, 2026 |
| William Andrew Macan | EVP, CLO and CS | 897,270 | 1.18% | Mar 24, 2026 |
| Daniel L. Reuvers | President and CEO | 1,500,000 | 1.97% | Mar 23, 2026 |
| Stephen Furlong | EVP, CFO and Treasurer | 410,053 | 0.54% | May 14, 2025 |
| Robert Cascella | Director | 798,017 | 1.05% | Nov 16, 2026 |
| Sasha Cucuz | Director | 3,056,294 | 4.01% | Nov 16, 2026 |
| Avinash Amin | Director | 30,000 | 0.04% | Jun 17, 2026 |
| Megan Rosengarten | Director | 170,890 | 0.22% | May 29, 2026 |
| Sheryl L. Conley | Director | 251,716 | 0.33% | May 29, 2026 |
| Glenn P. Muir | Director | 401,816 | 0.53% | May 29, 2026 |
| Jorey Chernett | 10% owner | 7,325,577 | 9.61% | Nov 13, 2026 |
| Madryn Select Opportunities, LP | 10% owner | 24,237,061 | 31.81% | Jun 17, 2026 |
| Madryn Health Partners Ii (Cayman Master), Lp | 10% owner | – | – | Jun 17, 2026 |
| Madryn Health Partners II, LP | 10% owner | 2,269,073 | 2.98% | Jun 17, 2026 |
| Madryn Health Advisors Ii, Lp | 10% owner | – | – | Jun 17, 2026 |
| Madryn Health Advisors Gp Ii, Llc | 10% owner | 17,044,940 | 22.37% | Jun 17, 2026 |
| Madryn Asset Management, LP | 10% owner | 17,333,542 | 22.75% | Jun 17, 2026 |
| Keith J. Sullivan | – | 1,590,924 | 2.09% | Mar 24, 2026 |
| Madryn Select Advisors Gp, Llc | 10% owner | – | – | Aug 12, 2025 |
| Madryn Select Advisors, Lp | 10% owner | – | – | Aug 12, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Sasha Cucuz Director | Nov 13, 2026 | Award | +370,370 | $1.35 | $500.00K | 995,370 |
| Jorey Chernett 10% owner | Nov 13, 2026 | Sale | −2,187,051 | $1.15 | $2.52M | 7,325,577 |
| Sasha Cucuz Director | Nov 12, 2026 | Other | +625,000 | $1.60 | $1.00M | 625,000 |
| Robert Cascella Director | Nov 12, 2026 | Award | +44,758 | $1.56 | $69.82K | 798,017 |
| Robert Cascella Director | Nov 12, 2026 | Award | +128,242 | $1.50 | $192.36K | 753,259 |
| Jorey Chernett 10% owner | Nov 12, 2026 | Sale | −706,840 | $1.43 | $1.01M | 9,512,628 |
| Jorey Chernett 10% owner | Nov 11, 2026 | Sale | −86,757 | $1.61 | $139.68K | 10,219,468 |
| Jorey Chernett 10% owner | Nov 9, 2026 | Buy | +40,000 | $1.99 | $79.60K | 10,306,225 |
| Jorey Chernett 10% owner | Nov 9, 2026 | Sale | −103,959 | $2.06 | $214.16K | 10,266,225 |
| Jorey Chernett 10% owner | Nov 6, 2026 | Sale | −250,804 | $2.39 | $599.42K | 10,370,184 |
| Jorey Chernett 10% owner | Oct 30, 2026 | Buy | +18,000 | $2.27 | $40.86K | 10,620,988 |
| Jorey Chernett 10% owner | Aug 14, 2026 | Buy | +14,000 | $3.16 | $44.24K | 10,602,988 |
| Nir Naor EVP, CFO & Treasurer | Jul 23, 2026 | Award | +500,000 | – | – | 500,000 |
| Jorey Chernett 10% owner | Jul 14, 2026 | Buy | +35,000 | $1.78 | $62.30K | 10,588,988 |
| Madryn Health Partners II, LP 10% owner | Jun 15, 2026 | Other | +4,634 | – | – | 2,269,073 |
| Madryn Health Partners II, LP 10% owner | Jun 15, 2026 | Other | +34,932 | – | – | 17,104,530 |
| Madryn Health Partners II, LP 10% owner | Jun 15, 2026 | Other | +2,934 | – | – | 1,435,958 |
| Avinash Amin Director | Jun 15, 2026 | Other | −4,634 | – | – | 30,000 |
| Avinash Amin Director | Jun 15, 2026 | Other | −34,932 | – | – | 34,634 |
| Avinash Amin Director | Jun 15, 2026 | Other | −2,934 | – | – | 69,566 |
| Madryn Health Partners II, LP 10% owner | May 28, 2026 | Other | +3,271 | – | – | 2,264,439 |
| Madryn Health Partners II, LP 10% owner | May 28, 2026 | Other | +24,658 | – | – | 17,069,598 |
| Madryn Health Partners II, LP 10% owner | May 28, 2026 | Other | +2,071 | – | – | 1,433,024 |
| Megan Rosengarten Director | May 28, 2026 | Award | +30,000 | – | – | 170,890 |
| Sheryl L. Conley Director | May 28, 2026 | Award | +30,000 | – | – | 251,716 |
| Glenn P. Muir Director | May 28, 2026 | Award | +30,000 | – | – | 401,816 |
| Robert Cascella Director | May 28, 2026 | Award | +36,250 | – | – | 625,017 |
| Avinash Amin Director | May 28, 2026 | Award | +30,000 | – | – | 72,500 |
| Sasha Cucuz Director | May 28, 2026 | Award | +30,000 | – | – | 1,542,798 |
| Jorey Chernett 10% owner | May 19, 2026 | Buy | +100,000 | $1.17 | $117.00K | 10,553,988 |
| Jorey Chernett 10% owner | May 12, 2026 | Buy | +475,000 | $1.34 | $636.50K | 10,453,988 |
| Jorey Chernett 10% owner | Apr 21, 2026 | Buy | +100,000 | $1.51 | $151.00K | 9,978,988 |
| Jorey Chernett 10% owner | Apr 20, 2026 | Buy | +100,000 | $1.58 | $158.00K | 9,878,988 |
| Jorey Chernett 10% owner | Mar 30, 2026 | Buy | +385,442 | $1.25 | $481.80K | 9,778,988 |
| Jorey Chernett 10% owner | Mar 27, 2026 | Buy | +500,000 | $1.35 | $675.00K | 9,393,276 |
| Jorey Chernett 10% owner | Mar 26, 2026 | Buy | +25,000 | $1.44 | $36.00K | 8,893,276 |
| Jorey Chernett 10% owner | Mar 25, 2026 | Buy | +125,000 | $1.40 | $175.00K | 8,868,276 |
| Daniel L. Reuvers President and CEO | Mar 23, 2026 | Award | +1,500,000 | – | – | 1,500,000 |
| Jorey Chernett 10% owner | Mar 20, 2026 | Buy | +169,472 | $1.41 | $238.96K | 8,743,276 |
| Steven Pfanstiel Former EVP, CFO and Treasurer | Mar 19, 2026 | Sale | −8,569 | $1.34 | $11.48K | 836,643 |
| Keith J. Sullivan – | Mar 19, 2026 | Sale | −46,289 | $1.34 | $62.03K | 1,590,924 |
| William Andrew Macan EVP, CLO and CS | Mar 19, 2026 | Sale | −16,005 | $1.34 | $21.45K | 897,270 |
| Steven Pfanstiel EVP, CFO and Treasurer | Mar 19, 2026 | Sale | −16,431 | $1.34 | $22.02K | 828,781 |
| Jorey Chernett 10% owner | Mar 19, 2026 | Buy | +450,000 | $1.33 | $598.50K | 8,573,804 |
| Jorey Chernett 10% owner | Mar 18, 2026 | Buy | +607,400 | $1.35 | $819.99K | 8,123,804 |
| Jorey Chernett 10% owner | Mar 17, 2026 | Buy | +531,000 | $1.16 | $615.96K | 7,516,404 |
| William Andrew Macan EVP, CLO and CS | Mar 17, 2026 | Award | +33,750 | – | – | 913,275 |
| Steven Pfanstiel EVP, CFO and Treasurer | Mar 17, 2026 | Award | +25,000 | – | – | 845,212 |
| Keith J. Sullivan President and CEO, Director | Mar 17, 2026 | Award | +112,500 | – | – | 1,637,213 |
| William Andrew Macan EVP, CLO and CS | Mar 4, 2026 | Sale | −609 | $1.34 | $816 | 879,525 |
| William Andrew Macan EVP, CLO and CS | Feb 26, 2026 | Sale | −3,427 | $1.35 | $4.63K | 880,134 |
| Keith J. Sullivan President and CEO, Director | Feb 26, 2026 | Sale | −8,452 | $1.35 | $11.41K | 1,524,713 |
| William Andrew Macan EVP, CLO and CS | Feb 23, 2026 | Award | +210,000 | – | – | 883,561 |
| Steven Pfanstiel EVP, CFO and Treasurer | Feb 23, 2026 | Award | +250,000 | – | – | 820,212 |
| Keith J. Sullivan President and CEO, Director | Feb 12, 2026 | Sale | −33,847 | $1.65 | $55.85K | 1,533,165 |
| William Andrew Macan EVP, CLO and CS | Feb 12, 2026 | Sale | −14,120 | $1.65 | $23.30K | 673,561 |
| Keith J. Sullivan President and CEO, Director | Feb 10, 2026 | Sale | −40,976 | $1.55 | $63.51K | 1,567,012 |
| William Andrew Macan EVP, CLO and CS | Feb 10, 2026 | Sale | −3,485 | $1.55 | $5.40K | 687,681 |
| Steven Pfanstiel EVP, CFO and Treasurer | Dec 30, 2025 | Award | +170,212 | – | – | 570,212 |
| William Andrew Macan EVP, GC, CCO and CS | Dec 30, 2025 | Award | +164,361 | – | – | 691,166 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Neuronetics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 102,433 shares on Sep 3, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Cory Anderson Officer | Nov 10, 2026 | 5,137 | $10.65K | Nov 10, 2026 | Restricted Stock Vesting |
| William Andrew Macan Former Officer | Aug 19, 2026 | 149,891 | $463.93K | Aug 19, 2026 | Restricted Stock Vesting |
| William Andrew Macan Officer | Aug 18, 2026 | 121,033 | $388.27K | Aug 18, 2026 | Restricted Stock Vesting |
| Keith J. Sullivan Former Officer and Director | Jun 8, 2026 | 42,164 | $54.35K | Jun 8, 2026 | Restricted Stock Vesting |
| William Andrew Macan Officer | Mar 19, 2026 | 16,005 | $21.12K | Mar 19, 2026 | Restricted Stock Vesting |
| Keith J. Sullivan Officer, Director | Mar 19, 2026 | 46,289 | $61.09K | Mar 19, 2026 | Restricted Stock Vesting |
| William Andrew Macan Officer | Mar 4, 2026 | 609 | $814 | Mar 4, 2026 | Restricted Stock Vesting |
| Keith J. Sullivan Officer, Director | Feb 26, 2026 | 8,452 | $11.37K | Feb 26, 2026 | Restricted Stock Vesting |
| William Andrew Macan Officer | Feb 26, 2026 | 3,427 | $4.61K | Feb 26, 2026 | Restricted Stock Vesting |
| William Andrew Macan Officer | Feb 12, 2026 | 14,120 | $23.24K | Feb 12, 2026 | Restricted Stock Vesting |
| Keith J. Sullivan Officer, Director | Feb 12, 2026 | 33,847 | $55.71K | Feb 12, 2026 | Restricted Stock Vesting |
| William Andrew Macan Officer | Feb 10, 2026 | 3,485 | $5.39K | Feb 10, 2026 | Restricted Stock Vesting |
| Keith J. Sullivan Officer, Director | Feb 10, 2026 | 40,976 | $63.40K | Feb 10, 2026 | Restricted Stock Vesting |
| Madryn Health Partners II, LP 10% Stockholder, Board Member | Aug 8, 2025 | 192,806 | $717.24K | Aug 8, 2025 | Merger/Acquisition |
| Madryn Select Opportunities, LP 10% Stockholder, Board Member | Aug 8, 2025 | 381,640 | $1.42M | Aug 8, 2025 | Merger/Acquisition |
See a number that looks wrong?